Literature DB >> 33173210

Neoadjuvant anti-CTLA4 and anti-PD1 blockade in advanced urothelial cancer.

Rebecca Tregunna1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33173210     DOI: 10.1038/s41585-020-00399-0

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial.

Authors:  Nick van Dijk; Alberto Gil-Jimenez; Karina Silina; Kees Hendricksen; Laura A Smit; Jeantine M de Feijter; Maurits L van Montfoort; Charlotte van Rooijen; Dennis Peters; Annegien Broeks; Henk G van der Poel; Annemarie Bruining; Yoni Lubeck; Karolina Sikorska; Thierry N Boellaard; Pia Kvistborg; Daniel J Vis; Erik Hooijberg; Ton N Schumacher; Maries van den Broek; Lodewyk F A Wessels; Christian U Blank; Bas W van Rhijn; Michiel S van der Heijden
Journal:  Nat Med       Date:  2020-10-12       Impact factor: 53.440

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.